DNA:NYSE
Ginkgo BioWorks
10,07 $US
arrow_downward
-2,00%(-0,20) 1J
10,02 $US
arrow_downward
-0,50% (-0,051)bedtimeAprès clôture
Fermé : 19 oct., 16:00:03 UTC−4 · USD
search
Tous les symboles
| Symbole | Cours | Variation | % variat. |
|---|
insights_autoGénération des principaux insights pour DNA...
Ouverture
10,38 $US
Élevé
10,50 $US
Faible
9,76 $US
Cap. boursière
647,91 M
Vol. moyen
2,94 M
Volume
2,48 M
+ haut sur 1 an
18,22 $US
+ bas sur 1 an
5,37 $US
BPA
-5,00 $US
Bêta
1,79
Actions en circulation
55,38 M
Nombre d'employés
485
Ouverture
10,38 $US
Élevé
10,50 $US
Faible
9,76 $US
Cap. boursière
647,91 M
Vol. moyen
2,94 M
Volume
2,48 M
+ haut sur 1 an
18,22 $US
+ bas sur 1 an
5,37 $US
BPA
-5,00 $US
Bêta
1,79
Actions en circulation
55,38 M
Nombre d'employés
485
Articles
Sources : Web et partenaires du secteur de l'information
Investing.com Canada
·
il y a 5 heures
Form 144 Ginkgo Bioworks Holdings For: 19 October By Investing.com
Stock Titan
·
il y a 6 heures
A 766-share sale proposed by Ginkgo Bioworks (DNA) officer Steve Coen includes shares to cover taxes.
https://www.dars.gov.et/
·
il y a 1 semaine
DNA Q2 2026 Earnings: Narrower-Than-Expected Loss Beats Consensus, but Shares Slide 7.57%
Profil
Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021. Wikipedia
À propos de Ginkgo BioWorks
PDGJason Kelly
Employés485
Date de création2008
Siège socialBoston, Massachusetts, États-Unis
Secteur-
Site Webginkgo.bio